Adrenoleukodystrophy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
 
Line 6: Line 6:


==Overview==
==Overview==
Adrenoleukodystrophy must be differentiated from  
Adrenoleukodystrophy must be differentiated from [[Leigh syndrome]], [[Niemann-Pick]] disease type C, Infantile Refsum disease, [[Zellweger syndrome]], [[Pyruvate dehydrogenase deficiency]], [[Arginase deficiency]], Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, [[Ataxia telangiectasia]], [[Pontocerebellar]] [[hypoplasias]], [[Metachromatic leukodystrophy]], [[Pelizaeus-Merzbacher]], [[Angelman syndrome]], [[Rett syndrome]], [[Lesch-Nyhan syndrome]], Miller-Dieker lissencephaly and Dopa-responsive [[dystonia]].


==Differential Diagnosis==
==Differential Diagnosis==

Latest revision as of 18:50, 23 June 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Adrenoleukodystrophy must be differentiated from Leigh syndrome, Niemann-Pick disease type C, Infantile Refsum disease, Zellweger syndrome, Pyruvate dehydrogenase deficiency, Arginase deficiency, Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, Ataxia telangiectasia, Pontocerebellar hypoplasias, Metachromatic leukodystrophy, Pelizaeus-Merzbacher, Angelman syndrome, Rett syndrome, Lesch-Nyhan syndrome, Miller-Dieker lissencephaly and Dopa-responsive dystonia.

Differential Diagnosis

Adrenoleukodystrophy must be differentiated from other diseases that cause neurological manifestations in infants.

Diseases Type of motor abnormality Clinical findings Laboratory findings and diagnostic tests Radiographic findings
Spasticity Hypotonia Ataxia Dystonia
Leigh syndrome - - + +
Niemann-Pick disease type C - - + +
  • Abnormal liver function tests
  • Fibroblast cell culture with filipin staining
Infantile Refsum disease - + + - Elevated plasma VLCFA levels --
Adrenoleukodystrophy + - - -
  • Elevated plasma VLCFA levels
  • Molecular genetic testing for mutations in the ABCD1 gene
--
Zellweger syndrome - + - - --
Pyruvate dehydrogenase deficiency + + + -
  • Elevated lactate and pyruvate levels in blood and CSF
  • Abnormal PDH enzymatic activity in cultured fibroblasts
--
Arginase deficiency + - - - --
Holocarboxylase synthetase deficiency - + - - Elevated levels of:
  • Beta-hydroxyisovalerate
  • Beta-methylcrotonylglycine
  • Beta-hydroxypropionate
  • Methylcitrate
  • Tiglylglycine
--
Glutaric aciduria type 1 - - - + Elevated levels of:
Ataxia telangiectasia - - + - --
Pontocerebellar hypoplasias - + - - Genetic testing for PCH gene mutations
Metachromatic leukodystrophy - + + -
  • Deficient arylsulfatase A enzyme activity in leukocytes or cultured skin fibroblasts
--
Pelizaeus-Merzbacher + - + -
Angelman syndrome - - + -
  • Methylation studies and chromosome microarray to detect chromosome 15 anomalies and UBE3A mutations
--
Rett syndrome + - - +
  • Occurs almost exclusively in females
  • Normal development during first six months followed by regression and loss of milestones
  • Loss of speech capability
  • Stereotypic hand movements
  • Seizures
  • Autistic features
  • Clinical diagnosis
  • Genetic testing for MECP2 mutations
--
Lesch-Nyhan syndrome + - - + --
Miller-Dieker lissencephaly + + - -
  • Cytogenetic testing for 17p13.3 microdeletion
--
Dopa-responsive dystonia + - - +
  • Onset in early childhood
  • Symptoms worsen with fatigue and exercise
  • Positive response to a trial of levodopa
--

References

Template:WH Template:WS